Rowe, Steven P.
Johnson, Geoffrey B.
Pomper, Martin G.
Gorin, Michael A.
Behr, Spencer C.
Article History
First Online: 16 May 2020
Compliance with ethical standards
:
: MGP is a co-inventor on a U.S. patent covering <sup>18</sup>F-DCFPyL and as such is entitled to a portion of any licensing fees and royalties generated by this technology. This arrangement has been reviewed and approved by the Johns Hopkins University in accordance with its conflict-of-interest policies. SPR is a consultant to Progenics Pharmaceuticals, the licensee of <sup>18</sup>F-DCFPyL. MAG has served as a consultant to Progenics Pharmaceuticals. SPR, MAG, and MGP receive research funding from Progenics Pharmaceuticals. There are no other potential conflicts of interest.